Abstract. State-of-the-art quantum-and interband-cascade-based chemical sensors may be effective new tools for the identification and quantification of trace gases in human breath for clinical uses. Increased or decreased concentrations of these molecules are associated with the pathogenesis of a large number of diseases. Current technologies enable breath analyses to be performed on a single breath and the results are available in real time. Critical parameters including sensor sensitivity, selectivity, real-time monitoring capability, robustness, cost, size, and weight determine the progress that made toward the development and availability of commercial diagnostic material. Subject terms: mid-infrared semiconductor-laser-based chemical sensor; realtime breath analysis; breath sampling; quantum cascade lasers; interband cascade lasers; single-frequency, tunable external cavity quantum cascade/interband lasers.
sampling breath is noninvasive, inherently safe to the subject, 54 and poses minimum risk to the person collecting the sample. 55 The only requirement to collect a breath sample is that the 56 subject must be breathing "normally". To Breath samples can 57 be collected easily and reproducibly in the field, in a clinic, 58 at the bedside, in the operating room, or in an intensive care 59 unit from infants to the elderly.
60
The ability to exchange oxygen for carbon dioxide is es-61 sential for many life forms. Generally, this gas exchange 62 occurs at the gas alveolar-blood capillary cellular interface 63 in the respiratory tract. Oxygen and carbon dioxide are pas-64 sively transported from blood to breath or vice versa, and 65 the diffusion of these gases is governed by their concen-66 tration gradients across the alveolar-capillary junction. Any 67 additional molecule present in the blood or in the inspi-68 ratory air will also pass into the breath or blood respec-69 tively. The only requirement for transport in the gas phase 70 is that molecules must exhibit significant vapor pressures. 71 The molecular profile of breath will be determined by the 72 composition of the inspiratory air and the volatile molecules 73 that are present in the blood. The origins of the volatiles in 74 blood are molecules and/or their metabolites that were in-75 haled previously (historical); molecules and/or their metabo-76 lites that entered the blood after dermal absorption; molecules 77 and/or their metabolites that are contained in ingested foods 78 and beverages; and molecules produced by cells (including 79 viruses, bacteria, fungi, and yeasts) or tissues in the body 80 including the mouth, nose, sinuses, airway, and the gastroin-81 testinal tract. The breath matrix (99.99%) is a mixture of 82 nitrogen, oxygen, carbon dioxide, water vapor, and the inert 83 gases. The remainder of breath (<100 ppm) is a mixture of 84 as many as 500 different compounds. The rates of excre-85 tion of molecules in breath are directly related to rates of 86 ventilation and cardiac output. The physical and chemical 87 properties of the molecules will also affect their rates of ex-88 cretion. If a molecule is lipid (fat) soluble it could be stored 89 in tissues not well perfused by blood, such as adipose tissue, 90 and thereby be released more slowly than a similar molecule 91 of diabetes especially when used in conjunction to the de-229 termination of serum glucose. 13 The combination of these 230 two was proposed since breath acetone was a more sensitive 231 indicator of poor control of diabetes than of serum glucose. 232 Also, 2-propanol has been found in the breath of nor-233 mal human subjects although at a lower concentration than 234 acetone.
14 The origin of 2-propanol has been postulated to 235 be the enzyme-mediated reduction of acetone; 2-propanol 236 has been observed in ketonemic subjects who have elevated 237 ratios of nicotinamide adenine dinucleotide and its reduced 238 form (NADH/NAD + ). The potential clinical use of breath 239 2-propanol is limited since this molecule is present at high 240 concentrations in most clinical environments.
241
Ethanol is normally found in human breath albeit at con-242 centrations of orders of magnitude less that the levels of 243 ethanol found in the breath of intoxicated subjects. The 244 source of this ethanol is intestinal bacteria that synthesize and 245 metabolize ethanol. Elevated concentrations of ethanol in the 246 breath of mice have been related to obesity, 15 and the concen-247 tration of breath ethanol was reduced when the mice were 248 treated orally to a poorly absorbed antibiotic (neomycin) . 249 This animal model suggests that obesity is a risk factor for the 250 development of fatty liver disease or nonalcoholic steatohep-251 atitis (NASH) in abstinent obese humans. Reduced intestinal 252 motility in obesity may increase the potential for the gut flora 253 to produce ethanol, may increase gut permeability, or may fa-254 vor bacterial overgrowth. Increased breath ethanol may pro-255 vide important information on the pathogenesis of NASH.
256
The origin of acetaldehyde found in normal human breath 257 is probably the oxidation of endogenously produced ethanol 258 since the concentration of acetaldehyde is always much lower 259 than ethanol. Abstinent men with the low-activity polymor-260 phism of alcohol dehydrogenase (ADH) or with low-activity 261 polymorphism of aldehyde dehydrogenase (ALDH) were 262 found to have high endogenous concentrations of ethanol 263 or acetaldehyde, respectively, in their blood.
16 Concentra-264 tions of breath ethanol or acetaldehyde could be a simple 265 way to identify humans with specific polymorphisms.
266
The origin of breath methanol may also be intestinal 267 bacterial flora or methanol may be produced in any tissue 268 when the leaving methyl groups are hydrolyzed. 17 Examples 269 are the conversion of S-adenosylmethionine to S-270 adenosylhomocysteine in various tissues. No studies have 271 reported breath profiles in human subjects with genetic de-272 fects in amino acid metabolism, although this is a potential 273 application of a methanol breath test. 371 This conclusion requires that the concentration profiles of 372 breath molecules be established for normal healthy human 373 subjects. Currently this information is not generally avail-374 able, and it is expected that the availability of breath sensors 375 can play a major role in solving this deficiency. Determin-376 ing the normal concentration ranges of breath molecules will 377 require that thousands of healthy subjects be studied on mul-378 tiple days.
379
The concentration profiles of breath molecules are dy-380 namic and change over a breath cycle. A typical breath fre-381 quency for relaxed tidal breathing is 10 or 12 breath/min. 382 The first part of the exhaled breath comes mainly from the 383 anatomical dead space and this volume is ∼1 ml/lb of the 384 ideal body weight. The remainder of the breath is called 385 mixed expired. The volume of gas exhaled over a single 386 breath is known as the tidal volume, and minute ventilation 387 is the volume of gas exhaled during 1 min. Minute ventilation 388 must provide enough oxygen to the lung epithelial cells to 389 meet the metabolic demands of all the body tissues. Hyper-390 ventilation or hypoventilation provides more or less than the 391 required amount of oxygen to the lung. The concentration 392 profiles of breath molecules in dead space air corresponds to 393 the atmospheric composition, i.e., ∼21% oxygen and 0.4% 394 carbon dioxide, whereas the main concentration profiles of 395 mixed expired air consists of ∼17% oxygen, 5% carbon diox-396 ide, and 5% water vapor. If breath analysis is to be used in the field of clinical anal-399 ysis it must either provide novel information not provided 400 by existing techniques or else provide results in a shorter 401 High optical power and single-frequency operation with good 508 spectral purity and wide wavelength tunability of the laser 509 source are the most critical characteristics for exhaled gas 510 sensing using spectroscopic techniques. A QCL with its cav-511 ity formed by Fresnel reflections at its end facets typically op-512 erates simultaneously in multiple longitudinal modes. Single-513 frequency operation is usually achieved by introducing a dis-514 tributed feedback (DFB) structure into the QCL active region 515 to favor a particular mode. Typically, the maximum tuning 516 range of DFB-QCLs achieved by changing the laser injection 517 current is 3 to 4 cm −1 . This can be increased to ∼20 cm −1 by 518 varying the temperature of the QCL chip. Because of the lim-519 ited tuning range and the precision required in the fabrication 520 of the embedded DFB structure, obtaining a DFB-QCL that 521 operates at precisely the desired wavelength is presently still 522 technically challenging. However, once obtained at the right 523 wavelength, a mid-IR DFB-QCL has the significant advan-524 tage of being very compact and robust, making it very useful 525 for monitoring a specific trace gas with resolved rotational 526 structure from small molecular species. However, a DFB-527 QCL, with its limited spectral tuning range, is not useful for 528 monitoring a gas with a congested rotational spectrum by 529 laser spectroscopy, since it is difficult to scan sufficiently far 530 to ascertain the band profile of a congested absorption band. 531 However, the spectral width of the QCL optical gain pro-532 file is usually significantly broader than 20 cm −1 , and there-533 fore QCLs can provide in fact a much broader wavelength 534 tuning range. Recent advances have resulted in very broad 535 gain profiles. The bound-to-continuum QCL design first pro-536 posed by Faist et al. 36 and the heterogeneous QC structure 537 first demonstrated by Gmachl et al. 37 as a supercontinuum 538 QCL, are the most promising structures in terms of broadband 539 emission, and have been further developed for wide single-540 mode-frequency tuning spectroscopic applications.
38-42

541
To take advantage of the broadband gain of such QCLs, 542 an external cavity (EC) configuration can be used to obtain 543 single-mode operation at any wavelength within the laser 544 gain profile. A widely tunable QCL spectrometer implement-545 ing a novel EC-QCL architecture for high-resolution spec-546 troscopic applications and multispecies trace-gas detection 547 was demonstrated 41 with a thermoelectrically cooled Fabry-548 Pérot gain medium operating in a cw mode at λ ∼5.28 μm 549 such an instrument depicted employs a piezoactivated 550 cavity mode tracking system for mode-hop-free operation. 551 The mode-tracking system provides independent control of 552 the EC length, diffraction grating angle, and laser current.
553
The QCL gain medium enabled a coarse laser frequency tun- 
582
Until now we have considered only intersubband QCLs.
583
The other type of mid-IR lasers are ICLs. These are a hybrid 584 of a diode laser and a cascade laser. The lasing transition 585 occurs when a conduction band electron confined in a quan-586 tum well of one material annihilates a quantum confined 587 hole in the valence band of a different material emitting a 588 photon. This is similar to a diode laser in that it involves 589 an interband transition, although with diode lasers only a 590 single material is typically involved. In a diode laser, each 591 electron is used only once, whereas in an ICL, an electron 592 in the valence band well tunnels out and is raised in energy 593 through a series of quantum wells until it possesses sufficient 594 energy for the lasing transition process to be repeated. Thus, 595 the same electrical current is used repeatedly in a cascade 596 process. Because ICLs have bandgap energy available, they 597 operate at shorter wavelengths than QCLs, typically in the 598 3-to 4-μm spectral region. [43] [44] [45] ICLs are more difficult to 599 fabricate, but they enable access to shorter mid-IR wave-600 lengths, which are particurly effective for the dedection of 601 such biomarkers as methane and ethane. 
Fundamentals of Exhaled Trace Gas Sensing 603
Generally, detection sensitivity, selectivity, and response time 604 are the primary requirements for trace gas sensing. For small 605 molecules with resolved rotational structure, selectivity is 606 obtained by choosing an absorption line that is free of in-607 terference from other species that might be present in the 608 sample. Furthermore, reducing the sample pressure sharp-609 ens the absorption line without reducing the peak absorption 610 until the linewidth begins to approach the Doppler width. 611 This sharpening of the absorption line also significantly im-612 proves selectivity. To obtain the best sensitivity, a strong 613 molecular absorption line must be selected, and a long ef-614 fective optical path length must be used. High sensitivity 615 requires that absorption from baseline variations and laser 616 and the astigmatic Herriott cell. 48 The basic configuration of 662 a long-path-length spectrometer is quite simple, comprising 663 a laser, followed by a multipass cell, and then a detector.
664
The basic measurement of the absorption involves a compar-
665
ison of three quantities, the signal at zero light, the signal 
Cavity enhanced techniques 673
Another way to obtain a very long path length is through 674 application of resonant optical cavities instead of using mul-675 tipass cells, CRDS, sometimes also referred to as cavity 676 leak out spectroscopy 33, 49-55 (CLEOS), is intrinsically back-677 ground free. When carried out with high-power pulsed lasers, 678 it is very simple to implement, requiring in addition to the 679 laser, only high-quality cavity mirrors, a reasonably fast de-680 tector, and suitable data acquisition. However, this technique 681 is harder to implement with QCLs, which have maximum 682 pulse powers only a few times their cw output. At the cost of 683 additional complexity, this power limitation can be overcome 684 by locking the cavity to the laser to fill the cavity followed by 685 rapid laser turn off. Alternatively, the cavity can be dithered 686 while a cw laser is scanned slowly. All of these approaches 687 are hindered by short ring-down times.
688
A more common method has been the direct measurement 689 of light absorption by the sample in the cavity. To avoid the 690 requirement that the cavity and laser must be locked together, 691 an effective approach has been to use off-axis integrated 692 cavity output spectroscopy 34, 56-58 (OA-ICOS). This method 693 is very closely related to LAS using a multipass cell with 694 the principal difference being that in ICOS, the beams are 695 allowed to overlap on the mirrors after many passes through 696 the cavity, thereby exciting high-order cavity modes. Another 697 approach for removing mode noise in OA-ICOS is to vibrate 698 the mirrors. This causes many mode hops to occur within the 699 time required to empty the cavity, effectively averaging out 700 this noise. Since there are no transparent holes in the mirrors 701 used in ICOS to admit and allow the exit of the laser beam, 702 ICOS requires more laser power, which is obtainable with 703 QCLs. A medical application of QCL-based OA-ICOS is the 704 measurement of NO and CO 2 in breath. 
PAS and QEPAS
706
PAS is based on the photoacoustic effect, in which acoustic 707 waves are produced by the absorption of modulated laser ra-708 diation by target trace gas species. By the use of an acoustic 709 cell, which is acoustically resonant at the modulation fre-710 quency, this is an effective method for sensitive trace gas 711 detection. In contrast to other IR absorption techniques, PAS 712 is an indirect technique in which the effect on the absorbing 713 medium and not the direct light attenuation is detected. Light 714 absorption results in a transient temperature effect, which 715 translates into pressure variations in the absorbing medium 716 that can be detected with a sensitive microphone. PAS is 717 ideally a background-free technique, since only the absorb-718 ing gas generates the signal. However, background signals 719 can originate from nonselective absorption of the gas cell 720 windows (coherent noise) and external acoustic (incoher-721 ent) noise. PAS signals are directly proportional to the pump 722 laser power and therefore maximum detection sensitivity can 723 be realized conveniently with the thermoelectrically cooled 724 (TEC) high-power QCLs and ICLs described in Sec. 3.1.
725
A novel approach to photoacoustic detection of trace gases 726 utilizing a quartz tuning fork (QTF) as a sharply resonant 727 acoustic transducer was first reported 27, 59, 60 in 2002. The 728 basic idea of QEPAS is to invert the common PAS approach 729 and accumulate the acoustic energy not in a gas-filled acous-730 tic cell but in a sharply resonant acoustic transducer. A natural 731 candidate for such a transducer is crystal quartz, because it 732 is a low-loss piezoelectric material. A nearly optimum com-733 mercially available quartz transducer can be found in a QTF 734 (see Fig. 3 
795
QEPAS excitation can also be performed in an ampli-796 tude modulation (AM) mode, and in this case, a coherent 797 acoustic background is present. This background is directly 798 proportional to the laser power reaching the spectrophone. 799 Therefore, the sensitivity limit is no longer determined by 800 the QTF thermal noise alone but by the laser power fluctua-801 tions and spurious interference features. The AM mode must 802 be used if the absorption feature of interest is spectrally so 803 wide that fast modulation of the laser wavelength across this 804 feature is not possible. This is the case for the large or heavy 805 molecules listed in Table 1 , when the individual rotational-806 vibrational transitions are not resolved and absorption bands 807 look unstructured. The performance of an AM 8.4-μm QCL-808 based QEPAS sensor system that demonstrated the detection 809 of broadband absorbing target species in the mid-IR spec-810 troscopic fingerprint region was reported in Ref. 71. Using a 811 similar approach, we developed 72 a QEPAS sensor employ-812 ing an EC-QCL targeting the unresolved absorption spectrum 813 of C 2 HF 5 (freon 125) at λ∼1150 cm −1 . The laser source ex-814 hibits single-frequency tuning of 180 cm −1 . In this sensor, 815 a photoacoustic signal is generated by turning the laser on 816 and off at the exact resonance frequency of the applied QTF. 817 The sensitivity of this AM-QEPAS-based sensor was deter-818 mined both for single-point measurement as well as in a 819 broadband wavelength scan using a calibration mixture of 820 15 ppm freon-125A in dry nitrogen. With a laser frequency 821 set to 1208.62 cm −1 , which corresponds to the maximum 822 absorption of freon 125 in this spectral region, continuous 823 concentration measurements were performed. A minimum 824 detection limit (1σ ) of ∼9 ppb was calculated for these con-825 ditions based on the scatter of the background signal mea-826 surements. The power and measurement bandwidth normal-827 ized noise equivalent absorption coefficient (NNEA) of this 828 sensor was determined to be 7.92×10 −9 cm −1 W Hz −1/2 for 829 freon 125. The applied cw TEC EC QCL provided ∼50 mW 830 of optical power. This corresponds to a minimum detection 831 absorption coefficient limit for C 2 HF 5 of ∼3.2×10 −7 cm −1 832 with 1-s averaging time. Figure 7 shows the basic FRS setup. The FRS signal is 895 measured by placing the sample between two polarizers, so 896 that the Faraday rotation can be detected as intensity mod-897 ulation of the light emerging from the second polarizer (an-898 alyzer). Two methods have been used for polarization ro-899 tation measurement: the so called 90-deg method uses two 900 polarizers with almost crossed polarization axes and a sin-901 gle photodetector for sensing of the transmitted light inten-902 sity and the second measurement method orients the ana-903 lyzer at 45 deg, splitting the beam into two polarizations 904 and uses two balanced detectors to detect that the beams 905 go out of balance when MCB is present. SNR enhancement 906 is achieved in slightly different ways for the two methods, 907 but fundamentally both are based on efficient suppression 908 of laser amplitude noise while maximizing the Faraday ro-909 tation signal. In both methods, the spectral shape of the 910 FRS signal is the sum of the differences between Zeeman 911 shifted dispersion curves. Since the polarization rotation and 912 thus the variation of the analyzer transmission exist only 913 when the NO molecules are present, FRS is considered a 914 zero optical background technique and provides ultrahigh 915 sensitivities.
916
In the 90-deg method, suppression of the laser noise is 917 achieved by nearly crossing the analyzer, thus reducing the 918 Ethane, a breath biomarker of lipid peroxidation, has the 1025 potential for broad clinical applications. The development 1026 of a compact system using OA-ICOS with a LN 2 cooled, 1027 cw, 4-mW DFB ICL operating at 3.35 μm (2986.7 cm −1 ) 1028 was used in real-time measurements of breath ethane.
1029
The ICOS cell length was 57 cm and the mirror diame-1030 ters were 5 cm with an effective internal cell volume of 1031 630 cm 3 . The ICOS cell mirrors had a specified reflectivity 1032 99.98% and the radius of curvature was 1 m. The ethane was 1033 pumped through the OA-ICOS cell using a small oil-free 1034 diaphragm pump. A Nafion R filter was used to remove any 1035 moisture and other polar molecules that are possible inter-1036 fering species. A 580-μm-diam flow-limiting orifice enables 1037 EC QCL provided a maximum power of 10 mW, and was 1099 tunable from 1196 to 1300 cm −1 . A strong absorption band 1100 results in a 0.1% absorption for a 1-m sampling cell filled with 1101 atmospheric pressure air, contaminated by 1 ppm of acetone 1102 vapor. This absorption was detected by traditional absorp-1103 tion spectroscopy using a pyroelectric detector. Wavelength 1104 modulation spectroscopy improves the detection limit up 1105 to 10 times and results in a 100 ppbv detection sensitivity. Although clinical breath analysis is currently in its in-1119 fancy, it offers unique capabilities to the field of medicine. 1120 Breath can be collected multiple times from humans without 1121 posing any risk to the subject or the person collecting the 1122 sample. Real-time monitors are currently being developed 1123 and these devices could be well suited for field and epi-1124 demiological studies, particularly for studies in developing 1125 countries where collecting blood and urine samples are diffi-1126 cult without refrigeration. If inexpensive, portable, real-time 1127 monitors can be developed, then chronically sick patients 1128 could monitor their progress in their home and thereby min-1129 imize their exposure to infections during routine visits to 1130 clinics. Breath analysis can be used to detect disease, moni-1131 tor disease progression, or monitor therapy. Breath analysis 1132 can be used for phase 1 and phase 2 clinical trials to mon-1133 itor new drug therapy or to detect potential adverse effects. 1134 Since breath analysis is noninvasive and can be performed 1135 easily, it allows larger numbers of subjects to be studied. If 1136 larger numbers of human subjects are studied, unusual ad-1137 verse effects of new pharmacologic agents are more likely to 1138 be identified earlier. 
